)
Visual
test
908 Devices
908 Devices (MASS) investor relations material
908 Devices Sidoti March Small-Cap Virtual Conference summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Sidoti March Small-Cap Virtual Conference summary18 Mar, 2026
Strategic transformation and business overview
Underwent a major transformation by divesting desktop products, focusing on handheld and portable analytical devices for public health, safety, and defense applications.
Expanded product portfolio from one to five handheld devices, with over 3,700 devices deployed and 18,000+ trained users globally.
Recurring revenue reached 35% in 2025, with a goal to maintain or grow this proportion through service and software offerings.
Diversified customer base, reducing reliance on large federal contracts and increasing state, local, and international sales.
Distribution model consolidated to a single partner for federal sales, with direct and distributor channels for other segments.
Financial performance and outlook
Achieved 18% year-over-year revenue growth in 2025, with adjusted gross margin rising to 57% and positive adjusted EBITDA in Q4.
Ended 2025 with $113 million in cash, up from $70 million in 2024, and expects to maintain a healthy cash balance.
Projected 2026 revenue growth of 15%-20%, further margin expansion, and a halving of adjusted EBITDA loss to mid-single-digit millions.
No significant supply chain disruptions reported; manufacturing consolidated in Danbury, CT, supporting margin improvement.
Path to cash flow positivity targeted for 2027-2028, with continued investment in R&D and international expansion.
Product innovation and growth drivers
Flagship MX908 mass spec device complemented by new FTIR-based products, including XplorIR and VipIR.
VipIR, launched in July 2025, integrates two optical technologies for robust sample identification and contributed $3 million in Q4 revenue.
XplorIR experienced 40% year-over-year growth, with over 150 units shipped in 2025.
AVCADD program with Smiths Detection expected to contribute $2-3 million in 2026 revenue.
Innovation pipeline includes connected services (Team Leader) and OEM partnerships, supporting future recurring revenue and platform expansion.
Explain VipIR's unique orthogonal technology
Detail the AVCAD program's 2026 revenue impact
Impact of NATO's 5% GDP target on modernization
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from 908 Devices
- Strong growth, innovation, and global expansion set the stage for profitability by 2027.MASS
Leerink Global Healthcare Conference 20269 Mar 2026 - Up to $100 million in securities to fund growth in handheld chemical analysis markets.MASSRegistration Filing9 Mar 2026
- Handheld detection tools, new products, and software drive growth and recurring revenue in 2026.MASSTD Cowen 46th Annual Health Care Conference4 Mar 2026
- 2025 revenue rose 18% to $56.2M, margins hit 57%, and Q4 Adjusted EBITDA turned positive.MASSQ4 20253 Mar 2026
- Q2 revenue up 16% to $14M; 2024 outlook reaffirmed at $63–$65M, with strong handheld growth.MASSQ2 20242 Feb 2026
- Handheld growth, RedWave integration, and innovation set the stage for future acceleration.MASSCanaccord Genuity 44th Annual Growth Conference & Private Company Showcase 20242 Feb 2026
- RedWave acquisition and product innovation drive growth, margin gains, and market expansion.MASSThe 44th Annual William Blair Growth Stock Conference31 Jan 2026
- Q3 revenue up 17%, but net loss widened on goodwill impairment and RedWave acquisition costs.MASSQ3 202415 Jan 2026
- Portfolio expansion, RedWave synergies, and operational changes position for growth in 2025.MASSStifel 2024 Healthcare Conference13 Jan 2026
Next 908 Devices earnings date
Q1 202612 May, 2026
908 Devices
Next 908 Devices earnings date
Q1 202612 May, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Explore our global coverage